Xbrane Biopharma AB: Xbrane attends Carnegie Nordi
Post# of 301275
Press release 2017-09-21
Xbrane is pleased to announce its participation in Carnegie Nordic Healthcare Day in New York in collaboration with the Trout Group, 5 December. The event is for institutional investors and is hosted at the offices of Davis Polk & Wardwell.
The Conference is organized by Carnegie Investment Bank, the Nordic market leader, and the Trout Group, the life science industry's leading investor relations and strategic advisory firm. Xbrane is one of more than 20 companies to present and hold 1 x 1 meetings. For institutional participation please contact events@carnegie.se .
Link to event: https://ebrdg.com/investor.php/c/carnegienordichealthcareday
About Xbrane Xbrane is a commercial phase Swedish biopharmaceutical company specialized in biosimilars and long acting injectables. Xbrane has world leading expertise in developing generics for long acting injectable drugs and proprietary high-yield protein expression technology for the development of biosimilars. Xbrane's headquarter is located in Solna outside of Stockholm and the company's in-house research and development facilities are located in Sweden and Italy. Xbrane is listed at Nasdaq First North since February 3 rd , 2016 under the name Xbrane and Avanza Bank AB is Xbrane's certified adviser. For more information see www.xbrane.com .
For further information, please contact: Martin Åmark CEO M: +46 (0) 763-093 777 E: martin.amark@xbrane.com
Susanna Helgesen CFO/IR, Xbrane Biopharma AB M: +46 (0) 708-278 636 E: susanna.helgesen@xbrane.com
Attachments:
(0)
(0)